SCHEMBL14050762

SCHEMBL14050762

Bc1cnn2c(NCc3ccc(C(=O)NCC4CC4)cc3)cc(-c3ccccc3F)nc12

nearest known ligand 0.54

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ GSK3B P49841 3/20 0.54
▸ CDK2 P24941 7/20 0.52
▸ CCNA2 P20248 1/20 0.46
▸ CCNA1 P78396 1/20 0.46
▸ VCP P55072 2/20 0.44
▸ NAMPT P43490 1/20 0.40
▸ MAPK14 Q16539 1/20 0.39
▸ USP30 Q70CQ3 1/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ CCNE1 P24864 1/20 0.39
▸ CDK7 P50613 1/20 0.39
▸ CCNH P51946 1/20 0.39
▸ MNAT1 P51948 1/20 0.39
▸ HDAC3 O15379 1/20 0.38
▸ HDAC1 Q13547 1/20 0.38
▸ GPR39 O43194 1/20 0.38
▸ CCNT1 O60563 1/20 0.38
▸ PDE4B Q07343 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12954287 0.90 GSK3B (0.68) GSK3BCDK2CCNA2CCNA1VCP
SCHEMBL13304914 0.90 GSK3B (0.54) GSK3BCDK2CCNA2CCNA1VCP
SCHEMBL14050764 0.88 GSK3B (0.53) GSK3BCDK2CCNA2CCNA1NAMPT
SCHEMBL12954300 0.88 GSK3B (0.53) GSK3BCDK2CCNA2CCNA1NAMPT
SCHEMBL13305326 0.87 GSK3B (0.56) GSK3BCDK2CCNA2CCNA1CCNE1
SCHEMBL12953665 0.86 GSK3B (0.63) GSK3BCDK2CCNA2CCNA1CCNE1
SCHEMBL12953517 0.86 GSK3B (0.54) GSK3BCDK2CCNA2CCNA1CCNE1
SCHEMBL13305401 0.86 GSK3B (0.56) GSK3BCDK2CCNA2CCNA1CCNE1
SCHEMBL14050780 0.85 GSK3B (0.60) GSK3BCDK2CCNA2CCNA1CCNE1
SCHEMBL14050761 0.85 GSK3B (0.55) GSK3BCDK2CCNA2CCNA1NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008130569-A1 NOVEL PYRAZOLOPYRIMIDINES AS CYCLIN DEPENDENT KINASE INHIBITORS SCHERING CORPORATION (US) 2008-10-30 — — WO disclosed
Send feedback